377 related articles for article (PubMed ID: 17185297)
1. Aspirin and ibuprofen enhance pyrazinamide treatment of murine tuberculosis.
Byrne ST; Denkin SM; Zhang Y
J Antimicrob Chemother; 2007 Feb; 59(2):313-6. PubMed ID: 17185297
[TBL] [Abstract][Full Text] [Related]
2. [Experimental evidence for Mycobacterium tuberculosis persistence in M. tuberculosis-infected H37RV mice in the treatment with 3 first-line drugs (rifampicin, isoniazid, pyrazinamide)].
Smirnova TG; Chernousova LN; Andreevskaia SN; Nikolaeva GM
Probl Tuberk Bolezn Legk; 2004; (3):32-7. PubMed ID: 15338898
[TBL] [Abstract][Full Text] [Related]
3. Activity of diclofenac used alone and in combination with streptomycin against Mycobacterium tuberculosis in mice.
Dutta NK; Mazumdar K; Dastidar SG; Park JH
Int J Antimicrob Agents; 2007 Oct; 30(4):336-40. PubMed ID: 17644321
[TBL] [Abstract][Full Text] [Related]
4. Treatment of an acute bacterial infection with a combination of acetylsalicylic acid/ibuprofen and interferon gamma.
Hockertz S; Heckenberger R
Arzneimittelforschung; 1996 Oct; 46(10):1012-5. PubMed ID: 8931897
[TBL] [Abstract][Full Text] [Related]
5. [A study on the activity of clofazimine with antituberculous drugs against Mycobacterium tuberculosis].
Lu Y; Wang B; Zhao WJ; Zheng MQ; Li P; Fu L; Liang BW
Zhonghua Jie He He Hu Xi Za Zhi; 2010 Sep; 33(9):675-8. PubMed ID: 21092635
[TBL] [Abstract][Full Text] [Related]
6. Low-dose aspirin and ibuprofen's sterilizing effects on Mycobacterium tuberculosis suggest safe new adjuvant therapies for tuberculosis.
Eisen DP; McBryde ES; Walduck A
J Infect Dis; 2013 Dec; 208(11):1925-7. PubMed ID: 23997233
[No Abstract] [Full Text] [Related]
7. Addition of PNU-100480 to first-line drugs shortens the time needed to cure murine tuberculosis.
Williams KN; Brickner SJ; Stover CK; Zhu T; Ogden A; Tasneen R; Tyagi S; Grosset JH; Nuermberger EL
Am J Respir Crit Care Med; 2009 Aug; 180(4):371-6. PubMed ID: 19520903
[TBL] [Abstract][Full Text] [Related]
8. [Prevention of resistance to rifampicin by pyrazinamide in experimental tuberculosis in the mouse].
Grosset J; Truffot-Pernot C; Poggi S; Lecoeur H; Chastang C
Rev Mal Respir; 1985; 2(4):205-8. PubMed ID: 3937188
[TBL] [Abstract][Full Text] [Related]
9. Biological evaluation of pyrazinamide liposomes for treatment of Mycobacterium tuberculosis.
El-Ridy MS; Mostafa DM; Shehab A; Nasr EA; Abd El-Alim S
Int J Pharm; 2007 Feb; 330(1-2):82-8. PubMed ID: 17049192
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy of tuberculosis in mice using single implants of isoniazid and pyrazinamide.
Gangadharam PR; Geeta N; Hsu YY; Wise DL
Int J Tuberc Lung Dis; 1999 Jun; 3(6):515-20. PubMed ID: 10383065
[TBL] [Abstract][Full Text] [Related]
11. [Activities of clofazimine against Mycobacterium tuberculosis in vitro and in vivo].
Lu Y; Zheng MQ; Wang B; Zhao WJ; Li P; Chu NH; Liang BW
Zhonghua Jie He He Hu Xi Za Zhi; 2008 Oct; 31(10):752-5. PubMed ID: 19080601
[TBL] [Abstract][Full Text] [Related]
12. [Sterilizing activity of the main drugs on the mouse experimental tuberculosis (author's transl)].
Grosset J; Truffot C; Fermanian J; Lecoeur H
Pathol Biol (Paris); 1982 Jun; 30(6):444-8. PubMed ID: 6810288
[TBL] [Abstract][Full Text] [Related]
13. Subcutaneous nanoparticle-based antitubercular chemotherapy in an experimental model.
Pandey R; Khuller GK
J Antimicrob Chemother; 2004 Jul; 54(1):266-8. PubMed ID: 15128731
[TBL] [Abstract][Full Text] [Related]
14. Mycobacterium tuberculosis from chronic murine infections that grows in liquid but not on solid medium.
Dhillon J; Lowrie DB; Mitchison DA
BMC Infect Dis; 2004 Nov; 4():51. PubMed ID: 15548322
[TBL] [Abstract][Full Text] [Related]
15. Calcitriol enhances pyrazinamide treatment of murine tuberculosis.
Zhang J; Guo M; Huang ZX; Bao R; Yu Q; Dai M; Wang X; Rao Y
Chin Med J (Engl); 2019 Sep; 132(17):2089-2095. PubMed ID: 31425356
[TBL] [Abstract][Full Text] [Related]
16. A once-weekly R207910-containing regimen exceeds activity of the standard daily regimen in murine tuberculosis.
Veziris N; Ibrahim M; Lounis N; Chauffour A; Truffot-Pernot C; Andries K; Jarlier V
Am J Respir Crit Care Med; 2009 Jan; 179(1):75-9. PubMed ID: 18948422
[TBL] [Abstract][Full Text] [Related]
17. Spectinamides are effective partner agents for the treatment of tuberculosis in multiple mouse infection models.
Robertson GT; Scherman MS; Bruhn DF; Liu J; Hastings C; McNeil MR; Butler MM; Bowlin TL; Lee RB; Lee RE; Lenaerts AJ
J Antimicrob Chemother; 2017 Mar; 72(3):770-777. PubMed ID: 27999020
[TBL] [Abstract][Full Text] [Related]
18. Lectin-functionalized poly (lactide-co-glycolide) nanoparticles as oral/aerosolized antitubercular drug carriers for treatment of tuberculosis.
Sharma A; Sharma S; Khuller GK
J Antimicrob Chemother; 2004 Oct; 54(4):761-6. PubMed ID: 15329364
[TBL] [Abstract][Full Text] [Related]
19. Significant increases in the levels of liver enzymes in mice treated with anti-tuberculosis drugs.
Lenaerts AJ; Johnson CM; Marrieta KS; Gruppo V; Orme IM
Int J Antimicrob Agents; 2005 Aug; 26(2):152-8. PubMed ID: 15953708
[TBL] [Abstract][Full Text] [Related]
20. [Comparison of inhibitory effect of rifalazil and rifampicin against Mycobacterium ulcerans infection induced in mice].
Nakanaga K; Saito H; Ishii N; Goto M
Kekkaku; 2004 May; 79(5):333-9. PubMed ID: 15211873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]